CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

April 19th, 2010

Will the FDA Halt Avandia Safety Study?

The Wall Street Journal reports that the FDA might terminate TIDE, the ongoing study testing the cardiovascular safety of rosiglitazone and pioglitazone. Alicia Mundy and Jennifer Corbett Dooren write that the agency could also choose to pull rosiglitazone from the U.S. market entirely. But the FDA won’t reach any decision until after an advisory panel meets in July.

Categories: General


You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.